Adam Kolom

Adam Kolom is a seasoned entrepreneur and investor with extensive expertise in life sciences and venture capital. As Cofounder and CEO of Related Sciences since April 2019, Adam leads a data science-driven drug discovery firm focused on optimizing preclinical medicine discovery. Adam also owns Startist Innovations, consulting on science-based product development and strategy since 2011. In advisory roles, Adam contributes to Every Cure and previously provided guidance for Parker Media and Emulate, Inc. Notably, Adam co-founded the Parker Institute for Cancer Immunotherapy, where leadership encompassed crafting strategic collaborations and facilitating significant funding initiatives. Prior experience includes managing a $150 million cancer-focused venture fund at the Cancer Research Institute and serving as an investment associate within General Atlantic's healthcare team. Adam holds a Bachelor of Science in Economics from The Wharton School.